Trials / Recruiting
RecruitingNCT06248151
Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-COVID-19 Syndrome
Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-Covid-19 Syndrome
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Nove de Julho · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to compare the acute cardiorespiratory and perceptual responses to a physical exercise session in those infected by Covid-19 with and without persistent symptoms.
Detailed description
The study will be a crossover carried out in two groups (with and without persistent symptoms of Covid-19). Participants in both groups will undergo a control session and an exercise session and cardiorespiratory and perceptual responses will be obtained before, during and after the sessions. In the exercise session, participants will perform aerobic exercises, strength exercises and muscle stretching, while in the control session participants will remain seated. Blood pressure, heart rate, cardiac autonomic modulation, peripheral oxygen saturation, vascular function and perception of affect will be obtained.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise session | Session will included aerobic, resistance and flexibility exercises and will last approximately 45 minutes. The session will begin with aerobic exercises (5 min jumping jacks and 5 min stationary walking). Then, nine strength exercises will be performed for the main muscle groups (3 times of 12 to 15 repetitions, with a 1-minute rest interval) and finally stretching for the main muscle groups |
| BEHAVIORAL | Control session | Remain seated for 60 min |
Timeline
- Start date
- 2024-02-15
- Primary completion
- 2024-12-30
- Completion
- 2025-07-30
- First posted
- 2024-02-08
- Last updated
- 2024-12-04
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06248151. Inclusion in this directory is not an endorsement.